Eleonora Mäkelä

Discovery of NOvel CIP2A VAriant (NOCIVA) and its clinical relevance in myeloid leukemias

R. Clark, J. Westermarck, V. Kähäri, 2020, bioRxiv.

Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia

J. Westermarck, U. Salmenniemi, M. Itälä-Remes, 2019, Cancers.

Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias

L. Elo, R. Clark, J. Westermarck, 2021, Clinical Cancer Research.

ARPP19 promotes MYC expression and associates with patient relapse in acute myeloid leukemia

J. Westermarck, U. Salmenniemi, M. Itälä-Remes, 2019, bioRxiv.